DossierENTITY

Breckenridge Pharmaceutical, Inc.

Coverage of Breckenridge Pharmaceutical, Inc. in the Nexus archive.

Earliest in view: Jun 14 · 02:30 UTCMost recent: Jun 14 · 02:30 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 14 · 02:30 UTCPIX11 NEW YORK
Popular antidepressant recalled in US over cancer-causing substance fears: FDA
The FDA has initiated a recall of Cymbalta antidepressant by Breckenridge Pharmaceutical due to potential cancer-causing substances. Over 14,000 bottles of Duloxetine delayed-release capsules are being recalled for treating depression, anxiety, and fibromyalgia.